Navigation Links
Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference
Date:4/9/2015

THE WOODLANDS, Texas, April 9, 2015 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at Needham & Company's 14th Annual Healthcare Conference on Wednesday, April 15, 2015 at 8:40 a.m. EST in New York.  Lexicon management will provide an overview of Lexicon's clinical development programs and milestones.

A webcast of the presentation will be available through Lexicon's website at www.lexpharma.com. An archived version of the presentation will be available at www.lexpharma.com until May 15, 2015.

About Lexicon
Lexicon is a biopharmaceutical company focused on developing breakthrough treatments for human disease.  Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to meet its capital requirements, successfully conduct preclinical and clinical development of its drug candidates, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

 


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexicon To Present At The Jefferies Global Healthcare Conference
2. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
3. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
4. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
5. Lexicon to Report Second Quarter Financial Results on July 30, 2013
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
7. Lexicon To Present At The Wedbush PacGrow Life Sciences Management Access Conference
8. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
9. Lexicon To Present At The Stifel Nicolaus Healthcare Conference
10. Lexicon To Report Third Quarter Financial Results On November 12, 2013
11. Lexicon To Present At The Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2020)... Vt. (PRWEB) , ... January 10, 2020 , ... By mid-January, many people’s New Year’s ... offering a “New Year, New Life” Eight Night Wellness Retreat for the 2020 season. , ... 2020 dates to include an extra week in May and the first weekend of October. ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... Institute of Silicon Valley, has this week announced the latest medical breakthrough for ... Molybdenum-Rhenium rod in a patient. , The newly FDA cleared MiRus Europa™ Pedicle ...
(Date:1/7/2020)... ... January 07, 2020 , ... Ironsphere, a ... providers, announced today it has been selected by MetLife Stadium for Privileged Access ... “As part of our ongoing commitment to maintain the highest of security policies, ...
Breaking Medicine Technology:
(Date:1/23/2020)... AVON, Colo. (PRWEB) , ... January 23, 2020 , ... ... (SCA), announced it will kick off its first-ever Save More Lives Challenge on Feb. ... engaging the public in lifesaving techniques that can decrease the number one cause of ...
(Date:1/22/2020)... LARGO, Fla. (PRWEB) , ... January 22, 2020 , ... ... will provide free dental services for low-income, underinsured individuals at its Largo, FL ... exams and x-rays , fillings , cleanings and ...
(Date:1/12/2020)... ... 2020 , ... Cecelia Health ( http://www.ceceliahealth.com ), a leading ... for over a decade to transform lives and health outcomes for patients and ... By optimizing the mix of expert clinician and digital touchpoints in clinically tested ...
(Date:1/10/2020)... ... ... WellHaven Pet Health, a family of companion animal veterinary hospitals headquartered in ... 2020, LEAD WELL with WOMEN. The community will be showcased at the VMX 2020 ... with WOMEN is to empower women, engage all, connect, and help you lead your ...
(Date:1/10/2020)... ... 10, 2020 , ... NW Women’s Fitness , a ... for all women. In search for a valuable nutrition solution, NW Women’s Fitness ... , For nearly 30 years, Balanced Habits, headquartered in Southern California, has helped ...
Breaking Medicine News(10 mins):